Abstract

Dr. Josef Messinger will speak about the integration of external discovery capabilities with the activities of internal projects. Focus will be on what kind of capabilities are needed and what is expected from external partners to be not only CRO’s but integral part of the research organization of a mid-sized pharma company.

Biography

Dr. Josef Messinger, Head of Structural Biology and Analytics, Global Medicine Design, R&D, Orion Pharma.

As Head of Structural Biology and Analytics, Josef is responsible for leading a team of experts in chromatography, mass spectrometry and nuclear magnetic resonance techniques. He is responsible for purification of small molecule up to the structural elucidation or proteins as well as the physico chemical characterization of small molecules.

Josef has performed his Diploma studies in Chemistry and received his doctoral grad in chemistry from the University of Duisburg, Germany.

In 1991, Josef started his career in pharma industry at Solvay Pharmaceutical in Hannover, as a Medicinal Chemists doing synthesis as well as modeling. During the time at Solvay Pharmaceutical Josef was responsible for lab automation, biotransformation and in the end leader of an international interdisciplinary project team for lung and heart diseases. In 2011 he moved to Orion Pharma as Senior Advisor in the medicinal chemistry department. He has been focusing on CNS diseases and major interest has been to understand protein ligand interactions. In 2020 he was appointed as Head of Structural Biology and Analytics in the current organization of Global Medicine Design.

Company profile

Register for